Showing 391-400 of 2216 results for "".
Navigating Therapy: Exploring FDA-Approved Treatments for Effective AAD Care
https://practicalneurology.com/programs/cme/navigating-therapy-exploring-fda-approved-treatments-for-effective-aad-care/27101/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Innovative Therapeutics: How Pathophysiology Guides New AAD Treatment Development
https://practicalneurology.com/programs/cme/innovative-therapeutics-how-pathophysiology-guides-new-aad-treatment-development/27100/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Mapping the Mind: The Pathophysiology That Drives AAD
https://practicalneurology.com/programs/cme/mapping-the-mind-the-pathophysiology-that-drives-aad/27098/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
https://practicalneurology.com/programs/cme/patient-centric-innovations-in-ms-care-high-efficacy-dmts-cognition-and-special-patient-populations/29172/Learn more about the use of high-efficacy DMTs in multiple sclerosis.Optimizing Outcomes in AAD in Community PCP and LTC Clinics
https://practicalneurology.com/programs/cme/optimizing-outcomes-in-aad-in-community-pcp-and-ltc-clinics/26712/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Building Better Strategies: Incorporating New AAD Treatments Into Clinical Practice
https://practicalneurology.com/programs/cme/building-better-strategies-incorporating-new-aad-treatments-into-clinical-practice/27102/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Treatment Response Assessment Tools for Relapsing Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treatment-response-assessment-tools-for-relapsing-multiple-sclerosis/33142/The authors explore available tools for assessing treatment response in relapsing multiple sclerosis and provide practical recommendations for their use in clinical practice.AAD Treatment Evolution: The Future of Emerging Therapies
https://practicalneurology.com/programs/cme/aad-treatment-evolution-the-future-of-emerging-therapies/27103/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Burden Beyond the Patient: AAD's Impact on Patients and Caregivers
https://practicalneurology.com/programs/cme/burden-beyond-the-patient-aads-impact-on-patients-and-caregivers/27094/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Early Warning: Clinical Signs of AAD Every PCP and Caregiver Should Know
https://practicalneurology.com/programs/cme/early-warning-clinical-signs-of-aad-every-pcp-and-caregiver-should-know/27095/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.